Updates

Plus500 - Q2 revenues up 162%!

September 2020

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

Plus500, the leading technology platform for trading contracts for difference, has shrugged off its previous problem of clients winning too much, with its latest update stating revenues for the six months ended 30th June increased 281% to US$564m with Q2 alone generating US$247.6m, an increase of 162% year-on-year. Importantly the period end position of customer trading reverted to insignificant historical levels. The performance was aided by “heightened volatility,” which drove a consistently high level of customer trading activity. In addition it onboarded 198,176 customers in H1 ’20 (H1 2019: 47,540) at an attractive cost, which ensured a record number of active customers trading on its platform. ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Polypipe

Scapa

Plus500 (January 2025)

Plus500 - Highest returning stock over past 11 years; eyes US and Japan for future growth (November 2024)

Plus500 - Has returned an incredible 11.5x its IPO market value via dividends and buy-backs! (October 2024)

Plus500 - CFD trading firm enjoys double-digit upgrade (February 2024)

Plus500 (September 2021)

Plus500 (June 2021)

Plus500 (April 2021)

Plus500 (December 2020)

Plus500 (November 2020)

Plus500 - Shares surge towards £15 (October 2020)

Plus500 (August 2020)

Plus500 - Second upgrade in a month (June 2020)

Plus500 - Significant director buying (April 2020)

Plus500 (February 2020)

Plus500 - Shares very cheap on ex-cash PE of 5.3 (December 2019)

Plus500 (September 2017)

Plus500 (January 2017)

Plus500 - Soon-to-be prospective PE just 6.6 (December 2016)

Plus500 - CFD trading firm a serious rival to IG (October 2016)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X